Skip to main content

Advertisement

Log in

Accountability in patenting of federally funded research

  • Patents
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

New data indicating underreporting of federal funding in academic biomedical patents highlight the pressing need for greater transparency under the Bayh-Dole Act.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2: Percentage of academic life sciences research federally funded by year.
Figure 3

References

  1. Bayh, B. US Senate Report of the Committee on the Judiciary on S.414 (US Government Printing Office, 1979).

  2. 35 USC Sections 202 (c)(1), (5) (reporting obligations); Section 202(c)(4), 203(a) (retained government rights).

  3. Rai, A.K. & Eisenberg, R.S. Law Contemp. Probl. 66, 289–314 (2003).

    Google Scholar 

  4. Rai, A.K., Allison, J. & Sampat, B. North Carolina L. Rev. 87, 101–115 (2009).

    Google Scholar 

  5. Ewing, T. & Feldman, R. Stan. Tech. L. Rev. 2012, 1–47 (2012).

  6. Smith, M. Inside Higher Ed, May 17, 2012. http://www.insidehighered.com/news/2012/05/17/higher-ed-split-merits-patent-company-intellectual-ventures

  7. Government Accountability Office. Technology Transfer: Agencies' Rights to Federally Funded Inventions (GAO, 2003).

  8. 563 US __ (2011).

  9. Brief for United States as Amicus Curiae, Stanford v. Roche. available at http://www.justice.gov/osg/briefs/2010/2pet/6invit/2009-1159.pet.ami.inv.pdf

  10. National Academies of Science. Managing University Intellectual Property in the Public Interest Merrill, S.A. & Mazza, A-M. (eds) (NAS, 2010).

  11. 35 USC Section 273 (e)(5).

  12. Government Accountability Office, Technology Transfer: Reporting Requirements for Federally Sponsored Invention Need Revision (GAO, 1999).

  13. Central Admixture Pharmacy Inc. v. Advanced Cardiac Solutions, P.C. 482 F.3d 1347 (Fed. Cir. 2007).

  14. 35 USC 203(a).

  15. Eisenberg, R. & Rai, A. Proprietary considerations. in 2 Handbook of Stem Cells: Embryonic Stem Cells (ed., Lanza, R.P.) 793–798 (Elsevier Academic, 2004).

    Chapter  Google Scholar 

  16. https://s-edison.info.nih.gov/iEdison

  17. Azoulay, P.R., Michigan, R. & Sampat, B.N. New Engl. J. Med. 357, 2049 (2007).

    Article  CAS  Google Scholar 

  18. Sampat, B.N. & Lichtenberg, F.R. Health Affairs 30, 332–339 (2011).

    Article  Google Scholar 

  19. 35 USC 201(e).

  20. 35 USC 202(c)(5).

  21. 37 CFR 401.14(h).

  22. 441 US 281 (1979).

Download references

Acknowledgements

Research reported in this publication was supported by the National Human Genome Research Institute of the US National Institutes of Health under Award Number P50HG003391. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute or the US National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arti K Rai.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rai, A., Sampat, B. Accountability in patenting of federally funded research. Nat Biotechnol 30, 953–956 (2012). https://doi.org/10.1038/nbt.2382

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2382

  • Springer Nature America, Inc.

This article is cited by

Navigation